Home/Pipeline/Aemcolo

Aemcolo

Travelers' diarrhea

ApprovedCommercial

Key Facts

Indication
Travelers' diarrhea
Phase
Approved
Status
Commercial
Company

About RedHill Biopharma

RedHill Biopharma is a publicly traded, Israel-based biopharmaceutical company with a mission to improve lives through innovative medicines targeting gastrointestinal diseases, infectious diseases, and oncology. The company has built a deep pipeline of late-stage clinical candidates, with a particular strategic focus on developing oral, broad-acting antiviral therapies for pandemic preparedness and medical countermeasures. RedHill operates with commercial infrastructure in both Israel and the United States, aiming to bring novel treatments to market for conditions with high unmet need.

View full company profile

Other Travelers' diarrhea Drugs

DrugCompanyPhase
Aemcolo® (rifamycin SV MMX®)Cosmo PharmaceuticalsApproved